CATALOGO DEI PRODOTTI DELLA RICERCA

PERBELLINI, Omar
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.637
NA - Nord America 5.067
AS - Asia 3.174
SA - Sud America 364
AF - Africa 36
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.298
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.963
RU - Federazione Russa 2.020
GB - Regno Unito 1.339
CN - Cina 1.298
SG - Singapore 1.099
DE - Germania 573
SE - Svezia 400
BR - Brasile 289
FI - Finlandia 280
IT - Italia 267
HK - Hong Kong 263
FR - Francia 261
IE - Irlanda 238
VN - Vietnam 193
CA - Canada 63
UA - Ucraina 60
KR - Corea 59
IN - India 50
NL - Olanda 48
BE - Belgio 40
TR - Turchia 38
JP - Giappone 37
MX - Messico 30
AR - Argentina 25
BD - Bangladesh 24
PL - Polonia 23
ES - Italia 22
ID - Indonesia 22
ZA - Sudafrica 18
IR - Iran 14
EC - Ecuador 13
UZ - Uzbekistan 13
AU - Australia 12
CO - Colombia 10
AT - Austria 9
CL - Cile 9
LT - Lituania 9
NP - Nepal 9
IQ - Iraq 7
RO - Romania 7
TW - Taiwan 7
KZ - Kazakistan 6
PE - Perù 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
HU - Ungheria 5
PK - Pakistan 5
BG - Bulgaria 4
CH - Svizzera 4
CZ - Repubblica Ceca 4
GR - Grecia 4
IL - Israele 4
AL - Albania 3
BO - Bolivia 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
JO - Giordania 3
KE - Kenya 3
MA - Marocco 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AZ - Azerbaigian 2
BJ - Benin 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
SI - Slovenia 2
TG - Togo 2
BH - Bahrain 1
CG - Congo 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MY - Malesia 1
NE - Niger 1
NG - Nigeria 1
NI - Nicaragua 1
PT - Portogallo 1
RS - Serbia 1
RW - Ruanda 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 14.297
Salva come PNG Salva come JPEG
Città #
Southend 1.149
Moscow 712
Chandler 584
Singapore 529
Dallas 514
Jacksonville 456
Ashburn 451
Woodbridge 421
Ann Arbor 397
Beijing 284
Hong Kong 258
Dublin 238
Munich 202
New York 175
Houston 133
Wilmington 125
Los Angeles 96
Jinan 95
The Dalles 95
Helsinki 88
Lawrence 87
Princeton 87
Nanjing 80
Verona 69
Shenyang 65
Tianjin 60
Ho Chi Minh City 55
Hanoi 47
Hebei 45
Turku 42
Buffalo 41
Falls Church 40
Brussels 38
Columbus 38
São Paulo 36
Haikou 35
Hangzhou 34
Ningbo 33
Tokyo 32
Nanchang 31
Zhengzhou 31
Boardman 30
Changsha 30
Guangzhou 28
Seoul 28
Stockholm 25
Montreal 24
Norwalk 24
Taiyuan 22
Groningen 21
Milan 21
Redondo Beach 21
Santa Clara 21
Manchester 20
Sindelfingen 20
Taizhou 20
Boston 19
Chicago 18
Seattle 18
Brooklyn 17
Dearborn 17
Jiaxing 17
Johannesburg 17
Chennai 16
Denver 16
Düsseldorf 16
Frankfurt am Main 16
Nürnberg 16
Warsaw 16
Fuzhou 15
London 15
Orem 15
Amsterdam 13
Dong Ket 13
Lanzhou 13
Bologna 12
Falkenstein 12
Redmond 12
San Francisco 12
Toronto 12
Jakarta 11
Kent 11
Phoenix 11
Redwood City 11
Tashkent 11
Haiphong 10
Washington 10
Augusta 9
Atlanta 8
Belo Horizonte 8
Council Bluffs 8
Lancaster 8
Poplar 8
San Jose 8
San Mateo 8
Auburn Hills 7
Mumbai 7
Padova 7
Ankara 6
Ardabil 6
Totale 8.919
Salva come PNG Salva come JPEG
Nome #
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 426
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 299
DEATH RECEPTOR 3 EXPRESSION AND SERUM LEVEL OF SOLUBLE TL1A CORRELATE WITH INDOLENT, EARLY STAGE B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 240
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 232
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies 228
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 222
A quantitative study on the growth variability of tumour cell clones in vitro 220
Analysis of B-cell receptor signal transduction in B-cell chronic lymphocytic leukemia by phosphospecific flow-cytometry 219
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 210
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients. 208
NON-CANONICAL NOTCH SIGNALING IN T-ALL: A PHOSPHO-FLOW CYTOMETRY STUDY 206
SINGLE-CELL PROFILES OF B-CELL RECEPTOR PHOSPHO-PROTEIN NETWORKS ASSOCIATED WITH PROGNOSIS AND PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA 200
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 199
BCR-signaling profiles associated with prognosis and progression in B-CLL 199
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 199
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 197
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 197
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 195
CXCL8 and interleukin-6 in B-cell chronic lymphocytic leukemia are up-reuglated through the activity of CXCL12 195
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 188
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 185
BCR-signaling profiles associated with prognosis and progression in B-CLL 184
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 184
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels 183
Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and hymenopteria allergy 180
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 180
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 177
A simple score predicts clonal mast cell disorders in patients with systemic reactions to Hymenoptera venom without skin lesions 177
Characterization of the cross-talk between human neutrophils and a subset of pro-inflammatory dendritic cells 174
Somatic D816V KIT mutation in a case of adult-onset familial mastocytosis. 174
Effects of wheat germ agglutinin on human gastrointestinal epithelium: insights from an experimental model of immune/epithelial cell interaction 173
METHODOLOGICAL APPROACH TO MINIMAL RESIDUAL DISEASE DETECTION BY FLOW CYTOMETRY IN ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA 171
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 171
A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis 170
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 170
Human neutrophils interact with both 6-sulfo LacNAc+ DC and NK cells to amplify NK-derived IFN{gamma}: role of CD18, ICAM-1 and ICAM-3 169
Jagged-1, Jagged-2 and DLL-1 are the elements of Notch signaling mainly responsible for the antiapoptotic effect on B-lineage acute lymphoblastic leukemia exerted by bone marrow Mesenchymal Stem Cells 168
Cross-talks within the innate immune system: the role of neutrophils 167
Immunomodulation after radiofrequency ablation of locally advanced pancreatic cancer by monitoring the immune response in 10 patients 165
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 165
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 162
IN VITRO STUDY OF THE MECHANISMS INVOLVED IN THE BONE MARROW MESENCHY- MAL STROMAL CELL MODULATORY EFFECT ON B CELL FUNCTIONS 161
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 161
Identification of granulocytic myeloid-derived suppressor cells (G-MDSCs) in the peripheral blood of Hodgkin and non-Hodgkin lymphoma patients 160
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 159
On the potential involvement of CD11d in co-stimulating the production of interferon-{gamma} by natural killer cells upon interaction with neutrophils via intercellular adhesion molecule-3 158
Human Bone marrow Mesenchymal Stem Cells protect B-cell Acute Lymphoblastic Leukemia from apoptosis in vitro by upregulation of Notch3 and Notch4 on both cell types 155
Improved detection of the C-KIT D816V mutation using allele-specific arms real time PCR assay allows a finer recognition of patients with indolent systemic mastocytosis. 155
Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells 154
In Vitro Study Of The Mechanisms Involved In The Bone Marrow Mesenchymal Stromal Cell Modulatory Effect On B Cell Function 153
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 150
Flow cytometry analysis of B-cell receptor phospho-protein networks in chronic lymphocytic leukemia 149
Underdiagnosed systemic mastocytosis: The role of flow cytometry 147
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 146
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 146
SIGNALING NETWORK IN T-CELL LYMPHOBLASTIC LEUKEMIA: RESULTS FROM A SINGLE-CELL MULTI-PARAMETRIC PHOSPHO-FLOW CYTOMETRY STUDY 144
Adult T-cell acute lymphoblastic leukemia: prognostic impact of myeloid associated antigens. 142
Up-regulation of CXCL8/interleukin-8 production in response to CXCL12 in chronic lymphocytic leukemia 139
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 139
Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis 139
Interleukin 7 requirement for survival of T-cell acute lymphoblastic leukemia and human thymocytes on bone marrow stroma. 139
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 137
IDENTIFICATION AND CHARACTERIZATION OF CANDIDATE MYELOID DERIVED SUP- PRESSOR CELLS IN THE MONONUCLEAR FRACTION OF PERIPHERAL BLOOD SAMPLES FROM PATIENTS AFFECTED BY NON-HODGKIN LYMPHOMA (NHL), HODGKIN LYMPHOMA (HL), AND MULTIPLE MYELOMA (MM) 136
Notch-3 and Notch-4 signaling rescues from apoptosis Human B-lineage Acute Lymphoblastic Leukemia cells in contact with Human Bone marrow-derived Mesenchymal Stromal Cells 135
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks 135
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia 132
Neutrophil activation and survival are modulated by interaction with NK cells 131
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 131
Epithelial-to-mesenchymal transition (EMT) induced by inflammatory priming elicits mesenchymal stromal cell-like immune-modulatory properties in cancer cells 129
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 129
Serum tryptase levels differently change over time in indolent systemic mastocytosis with or without skin lesions. 128
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 123
High incidence of autoimmune complications in 82 patients with non-MALT marginal zone lymphomas. 120
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 119
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 118
Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia 110
Systemic Reactions After Hymenoptera Sting And Raised Serum Tryptase Strongly Suggest Clonal Mast Cells Disorders 108
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases 107
EPSTEIN-BARR VIRUS DNA LOAD IN CHRONIC LYMPHOCYTIC LEUKEMIA IS AN INDEPENDENT PREDICTOR OF CLINICAL COURSE AND SURVIVAL 107
Ultra-Deep Sequencing (UDS) Allows More Sensitive Detection of the D816V and Other Kit Gene Mutations in Systemic Mastocytosis 104
Flow-cytometric detection of minimal residual disease in adult acute lymphoblastic leukemia 100
Multi-parametric phospho-flow cytometry in T-call Acute Lymphoblastic Leukemia 100
Evans syndrome secondary to chronic lymphocytic leukaemia: presentation, treatment, and outcome 94
Rituximab, bendamustine and cytarabine (R-BAC) in patients with relapsed-refractory aggressive B-cell lymphoma 93
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia 92
On the co-purification of 6-sulfo LacNAc(+) dendritic cells (slanDC) with NK cells enriched from human blood. 90
Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells 84
Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders 83
null 70
Prognostic relevance of oxidative stress measurement in chronic lymphocytic leukaemia 63
null 55
Totale 14.387
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.422
article - articoli 22.184
book - libri 0
conference - conferenze 21.238
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021411 0 0 0 0 0 95 13 49 33 13 172 36
2021/2022872 86 257 5 83 68 33 20 48 40 23 60 149
2022/20231.667 103 192 134 320 135 403 17 99 206 13 33 12
2023/2024938 51 72 55 76 102 209 60 66 7 47 126 67
2024/20252.148 95 149 85 342 64 95 146 100 359 127 208 378
2025/20264.435 441 385 488 1.151 1.691 279 0 0 0 0 0 0
Totale 14.387